Guest guest Posted January 7, 2011 Report Share Posted January 7, 2011 McGuff IV vitamin C FDA warning letter McGuff Pharmaceuticals Inc. 28 Dec 2010 Unapproved New Drug and Misbranding Violations In addition to violating CGMPs, you manufacture and market unapproved new drugs in violation of sections 505(a) and 502(f)(1) [21 U.S.C. §§ 355(a) and 352(f)(1)] of the Act. Based on the information your firm submitted to FDA's Drug Registration and Listing System and the information collected during the inspection of your facility, you manufacture the following prescription drugs, including, but not limited to: * Ascor L 500, Ascorbic Acid Injection, USP, 500 mg/mL in 50 mL vial (McGuff Pharmaceuticals) * Ascorbic Acid Injection, USP, 500 mg/mL in a 50 mL vial (((6)) These products are drugs within the meaning of section 201(g) of the Act, [21 U.S.C. § 321(g)] because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of diseases. Further, they are " new drugs " within the meaning of section 201(p) of the Act [21 U.S.C. § 321(p)] because they are not generally recognized as safe and effective for their labeled uses. Under sections 301(d) and 505(a) of the Act [21 U.S.C. §§ 331(d) and 355(a)] a new drug may not be introduced into or delivered for introduction into interstate commerce unless an application approved by FDA under either section 505( or (j) of the Act [21 U.S.C. § 355( or (j)] is in effect for the drug. Based on our information, you do not have any FDA-approved applications on file for these drug products. The marketing of these products, or other applicable products, without an approved application constitutes a violation of these provisions of the Act. Additionally, because the above products are intended for conditions that are not amenable to self-diagnosis and treatment by individuals who are not medical practitioners, adequate directions cannot be written for them so that a layman can use this product safely for its intended uses. Consequently, their labeling fails to bear adequate directions for their intended uses, causing it to be misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)] Because your products lack required approved applications, they are not exempt under 21 C.F.R. § 201.115 from the requirements of section 502(f)(1) of the Act. The introduction or delivery for introduction into interstate commerce of these products therefore violates sections 301(a) of the Act [21 U.S.C § 331(a)]. You should discontinue manufacturing and distributing all of your unapproved drugs at all facilities immediately. For questions about the regulatory status of your drugs, contact Kathleen Joyce, at 301-796-3329. For assistance in communicating with the FDA concerning the application process for your unapproved drug(s), contact FDA's unapproved drugs coordinator, Dr. Sally Loewke, at 301-796-0710. .... You should take prompt action to correct the violations cited in this letter. Failure to promptly correct these violations may result in legal action without further notice including, without limitation, seizure and injunction. Other federal agencies may take this Warning Letter into account when considering the award of contracts. Additionally, FDA may withhold approval of requests for export certificates, or approval of pending drug applications listing your facility, until the above violations are corrected. FDA may re-inspect to verify corrective actions have been completed. Within fifteen working days of receipt of this letter, please notify this office in writing of the specific steps that you have taken to correct violations. Include an explanation of each step being taken to prevent the recurrence of violations and copies of supporting documentation. If you cannot complete corrective action within fifteen working days, state the reason for the delay and the date by which you will have completed the correction. Additionally, your response should state if you no longer manufacture or distribute the drug products manufactured at this facility, and provide the date(s) and reason(s) you ceased production. For discontinued products, you must update the Drug Listing files in accordance with 21 C.F.R. § 207.30(a)(2). Sincerely, Alonza E. Cruse District Director http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm238251.htm Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 7, 2011 Report Share Posted January 7, 2011 FDA is just as bad as the drug co. , follow the $ trail. Someday in the near future the FDA will be shut down, here again they do more harm then good Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 7, 2011 Report Share Posted January 7, 2011 Rather than “shut down†the needed regulatory agency, let’s just get rid of the money influence of the drug Company lobbyists and legislators that enjoy the Drug Company Money. The FDA often does the right thing but too often does the wrong thing. Can you imagine the drug companies with nobody riding shotgun? I can’t. When we understand that Government is ‘people’ then we come to the conclusion that it is people’s greed, not the word ‘Government’ which too many are labeling as the problem. It is corporate greed that is the problem along with people and Legislators that feed off it. “The Cost of Civilization, is government†and I’m sorry I don’t know who produced that quote but it is reality because anarchy, which is the condition without government, the free-for-all, would be horrendous. We simply must work harder to make government work for us because no matter what country you live in you face the same problem and sorry to say, the United States ranks amongst the worst as regarding safeguarding We The People. Joe C. From: gary williams Sent: Friday, January 07, 2011 12:12 PM FDA is just as bad as the drug co. , follow the $ trail. Someday in the near future the FDA will be shut down, here again they do more harm then good Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 7, 2011 Report Share Posted January 7, 2011 The FDA has been going after all manufacturers of IV vitamin C and of EDTA - both quite non-toxic. Obviously these meds have greater value than we suspected. Historical parallels tell us that the pharmaceutical industry is developing semi-toxic high-priced versions of these that will prescriptive control. I remember watching a Viet Nam era documentary where General Westmoreland was standing amidst a group of laughing, admiring wounded soldiers, when the General spotted a soldier in the group who was wearing no bandages. The General immediately lost his own fatuously jovial attitude and showed immediate rage, " Why aren't you shot? " he demanded to know. Many on this list, including myself, have gone to a clinic for a history and physical, only to be met with confusion and disbelief when we inform them that we are taking no prescription drugs. The feeling is that there is something wrong with us if we are healthy. The docs will even write it up in a negative way: " The patient denies any symptoms of. " Eventually those who claim ownership of our health will become enraged that you have escaped their clutches. I think it is smart to let these people give you all the pills they want, just don't let them clog your toilet. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.